Search

Your search keyword '"C. De Ciuceis"' showing total 63 results

Search Constraints

Start Over You searched for: Author "C. De Ciuceis" Remove constraint Author: "C. De Ciuceis" Search Limiters Full Text Remove constraint Search Limiters: Full Text
63 results on '"C. De Ciuceis"'

Search Results

1. P141 COMPARISON BETWEEN TECHNIQUES OF EVALUATION MICROVASCULAR MORPHOLOGY: THE GOLD-STANDARD LOCALLY INVASIVE MICROMYOGRAPHY VS. THREE NON-INVASIVE TECHNIQUES. PRELIMINARY DATA

2. 5.7 SUBPOPULATIONS OF CIRCULATING T LYMPHOCYTES IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY

3. 5.6 LONG-TERM TREATMENT WITH MELATONIN MAI IMPROVE ANTICONTRACTILE ACTIVITY OF PERIVASCULAR FAT IN OBESE MICE

4. 3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES

6. P2.01 RELATIONSHIP BETWEEN MEDIA TO LUMEN RATIO OF SUBCUTANEOUS SMALL ARTERIES AND WALL TO LUMEN RATIO OF RETINAL ARTERIOLES EVALUATED NON INVASIVELY BY SCANNING LASER DOPPLER FLOWMETRY

10. Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals

11. POS0593 THE REDUCTION OF RETINAL MICROVASCULAR ALTERATIONS AND THE DECREASE OF A POTENTIALLY RELATED T-CELL SUBSET IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT

12. SKIN CAPILLARY ALTERATIONS IN PATIENTS WITH ACUTE SARS-COV-2 INFECTION

13. NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK

14. POSSIBLE ROLE OF THE SPLEEN IN THE DEVELOPMENT OF HYPERTENSION IN HUMANS

15. Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II-induced hypertension in rats

16. Role of β-Adrenergic Receptors on Nitric Oxide-Dependent Tissue-Type Plasminogen Activator (t-PA) Release in Normotensive Subjects and Hypertensive Patients

17. Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus

18. 5.7 SUBPOPULATIONS OF CIRCULATING T LYMPHOCYTES IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY

19. 3.1 THE EFFECTS OF ANTICONTRACTILE PROPERTY OF PERIVASCULAR ADIPOSE TISSUE IN OBESE MICE

20. 7.3 MICROCIRCULATION ABNORMALITIES AS RELATED TO ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

21. Decreased number of circulating endothelial progenitor cells in patients with Graves’ hyperthyroidism

22. Decreased number of circulating endothelial progenitor cells in patients with Graves’ hyperthyroidism

23. The vasoconstriction induced by endothelin-1 in subcutaneous small resistance arteries of normotensive and hypertensive subjects is mediated mainly by ETA receptors

24. Long-term treatment with melatonin may increase anticontractile activity of perivascular fat in obese mice

25. 3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES

26. P2.01 RELATIONSHIP BETWEEN MEDIA TO LUMEN RATIO OF SUBCUTANEOUS SMALL ARTERIES AND WALL TO LUMEN RATIO OF RETINAL ARTERIOLES EVALUATED NON INVASIVELY BY SCANNING LASER DOPPLER FLOWMETRY

27. Effects of losartan and enalapril at different doses on matrix proteins in the heart of spontaneously hypertensive rats (SHR)

28. INCREASED INTERLEUKIN-18 PLASMA LEVELS IN HYPERTENSIVE PATIENTS AFTER ORAL GLUCOSE TOLERANCE TEST: 8B.07

29. P11.06 FIBRONECTIN, BUT NOT LAMININ CONTENT IS INCREASED IN THE TUNICA MEDIA OF SUBCUTANEOUS SMALL RESISTANCE ARTERIES OF PATIENTS WITH ESSENTIAL HYPERTENSION

30. 6.14 Activation of the Renin-Angiotensin-Aldosterone System during Drospirenone Administration for Contraception

31. 12.7 Organ Culture is Not a Suitable Model to Study Angiotensin II-Induced Remodelling in Resistance-Sized Arteries of Spontaneously Hypertensive Rats (SHR)

32. 12.15 Effect of Anti-Hypertensive Treatment on Circulating Endothelial Progenitor Cells in Patients with Mild Essential Hypertension

33. Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers-Danlos Syndrome: Focus on Vascular Prevention.

34. Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade.

35. Influence of Perivascular Adipose Tissue on Microcirculation: A Link Between Hypertension and Obesity.

36. Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease?

37. Microcirculation and Physical Exercise In Hypertension.

38. Case report: Area of focus in a case of malignant hypertension.

39. Unattended versus Attended Blood Pressure Measurement: Relationship with Retinal Microcirculation.

40. Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.

41. New Noninvasive Methods to Evaluate Microvascular Structure and Function.

42. Immune System and Microvascular Remodeling in Humans.

43. Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs.

44. The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans.

46. Unattended Versus Attended Blood Pressure Measurement.

47. Decreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery.

48. Effects of a long-term treatment with aliskiren or ramipril on structural alterations of subcutaneous small-resistance arteries of diabetic hypertensive patients.

49. Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients.

50. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients.

Catalog

Books, media, physical & digital resources